General
Preferred name
iobenguane (131I)
Synonyms
Metaiodobenzylguanidine I-131 ()
IOBENGUANE I 131 ()
IOBENGUANE ()
Iobenguane, i-131 ()
Iobenguane (131 i) ()
Azedra ()
Mibg i-131 ()
(131i)-mibg ()
131i-mibg ()
3-iodobenzylguanidine, i-131 ()
M131Ibg ()
131 i-mibg ()
Iodine (131i) iobenguane ()
IOBENGUANE I-131 ()
I-131 metaiodobenzylguanidine ()
3-iodobenzylguanidine (131i) ()
P&D ID
PD072005
CAS
77679-27-7
Tags
natural product
drug
Approved by
PMDA
FDA
First approval
1994
2018
Drug indication
Diagnostic Aid
Neuroendocrine cancer
Neuroblastoma
Pheochromocytoma
Radioactive Agent
Drug Status
approved
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Iobenguane I 131 is a guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Molecular Weight
278.99
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.27
TPSA
61.9
Fraction CSP3
0.12
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
